• Je něco špatně v tomto záznamu ?

GABAB receptor phosphorylation regulates KCTD12-induced K⁺ current desensitization

L. Adelfinger, R. Turecek, K. Ivankova, AA. Jensen, SJ. Moss, M. Gassmann, B. Bettler,

. 2014 ; 91 (3) : 369-79.

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc15023204

GABAB receptors assemble from GABAB1 and GABAB2 subunits. GABAB2 additionally associates with auxiliary KCTD subunits (named after their K(+) channel tetramerization-domain). GABAB receptors couple to heterotrimeric G-proteins and activate inwardly-rectifying K(+) channels through the βγ subunits released from the G-protein. Receptor-activated K(+) currents desensitize in the sustained presence of agonist to avoid excessive effects on neuronal activity. Desensitization of K(+) currents integrates distinct mechanistic underpinnings. GABAB receptor activity reduces protein kinase-A activity, which reduces phosphorylation of serine-892 in GABAB2 and promotes receptor degradation. This form of desensitization operates on the time scale of several minutes to hours. A faster form of desensitization is induced by the auxiliary subunit KCTD12, which interferes with channel activation by binding to the G-protein βγ subunits. Here we show that the two mechanisms of desensitization influence each other. Serine-892 phosphorylation in heterologous cells rearranges KCTD12 at the receptor and slows KCTD12-induced desensitization. Likewise, protein kinase-A activation in hippocampal neurons slows fast desensitization of GABAB receptor-activated K(+) currents while protein kinase-A inhibition accelerates fast desensitization. Protein kinase-A fails to regulate fast desensitization in KCTD12 knock-out mice or knock-in mice with a serine-892 to alanine mutation, thus demonstrating that serine-892 phosphorylation regulates KCTD12-induced desensitization in vivo. Fast current desensitization is accelerated in hippocampal neurons carrying the serine-892 to alanine mutation, showing that tonic serine-892 phosphorylation normally limits KCTD12-induced desensitization. Tonic serine-892 phosphorylation is in turn promoted by assembly of receptors with KCTD12. This cross-regulation of serine-892 phosphorylation and KCTD12 activity sharpens the response during repeated receptor activation.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15023204
003      
CZ-PrNML
005      
20150728103932.0
007      
ta
008      
150709s2014 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.bcp.2014.07.013 $2 doi
035    __
$a (PubMed)25065880
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Adelfinger, Lisa $u Department of Biomedicine, University of Basel, 4056 Basel, Switzerland. $7 gn_A_00001710
245    10
$a GABAB receptor phosphorylation regulates KCTD12-induced K⁺ current desensitization / $c L. Adelfinger, R. Turecek, K. Ivankova, AA. Jensen, SJ. Moss, M. Gassmann, B. Bettler,
520    9_
$a GABAB receptors assemble from GABAB1 and GABAB2 subunits. GABAB2 additionally associates with auxiliary KCTD subunits (named after their K(+) channel tetramerization-domain). GABAB receptors couple to heterotrimeric G-proteins and activate inwardly-rectifying K(+) channels through the βγ subunits released from the G-protein. Receptor-activated K(+) currents desensitize in the sustained presence of agonist to avoid excessive effects on neuronal activity. Desensitization of K(+) currents integrates distinct mechanistic underpinnings. GABAB receptor activity reduces protein kinase-A activity, which reduces phosphorylation of serine-892 in GABAB2 and promotes receptor degradation. This form of desensitization operates on the time scale of several minutes to hours. A faster form of desensitization is induced by the auxiliary subunit KCTD12, which interferes with channel activation by binding to the G-protein βγ subunits. Here we show that the two mechanisms of desensitization influence each other. Serine-892 phosphorylation in heterologous cells rearranges KCTD12 at the receptor and slows KCTD12-induced desensitization. Likewise, protein kinase-A activation in hippocampal neurons slows fast desensitization of GABAB receptor-activated K(+) currents while protein kinase-A inhibition accelerates fast desensitization. Protein kinase-A fails to regulate fast desensitization in KCTD12 knock-out mice or knock-in mice with a serine-892 to alanine mutation, thus demonstrating that serine-892 phosphorylation regulates KCTD12-induced desensitization in vivo. Fast current desensitization is accelerated in hippocampal neurons carrying the serine-892 to alanine mutation, showing that tonic serine-892 phosphorylation normally limits KCTD12-induced desensitization. Tonic serine-892 phosphorylation is in turn promoted by assembly of receptors with KCTD12. This cross-regulation of serine-892 phosphorylation and KCTD12 activity sharpens the response during repeated receptor activation.
650    _2
$a alanin $x genetika $x metabolismus $7 D000409
650    _2
$a substituce aminokyselin $7 D019943
650    _2
$a zvířata $7 D000818
650    _2
$a CHO buňky $7 D016466
650    _2
$a kultivované buňky $7 D002478
650    _2
$a Cricetulus $7 D003412
650    _2
$a proteinkinasy závislé na cyklickém AMP $x metabolismus $7 D017868
650    _2
$a proteiny vázající GTP $x metabolismus $7 D019204
650    _2
$a hipokampus $x cytologie $x metabolismus $7 D006624
650    _2
$a myši $7 D051379
650    _2
$a myši knockoutované $7 D018345
650    _2
$a neurony $x metabolismus $7 D009474
650    _2
$a metoda terčíkového zámku $7 D018408
650    _2
$a fosforylace $7 D010766
650    _2
$a draslík $x metabolismus $7 D011188
650    _2
$a receptory GABA $x genetika $x metabolismus $7 D018079
650    _2
$a receptory GABA-B $x genetika $x metabolismus $7 D018080
650    _2
$a serin $x genetika $x metabolismus $7 D012694
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Turecek, Rostislav $u Department of Biomedicine, University of Basel, 4056 Basel, Switzerland; Institute of Experimental Medicine, ASCR, Videnska 1083, 14220 Prague 4-Krc, Czech Republic.
700    1_
$a Ivankova, Klara $u Department of Biomedicine, University of Basel, 4056 Basel, Switzerland.
700    1_
$a Jensen, Anders A $u Department of Biomedicine, University of Basel, 4056 Basel, Switzerland.
700    1_
$a Moss, Stephen J $u Department of Neuroscience, Tufts University School of Medicine, Boston, MA 02111, United States.
700    1_
$a Gassmann, Martin $u Department of Biomedicine, University of Basel, 4056 Basel, Switzerland.
700    1_
$a Bettler, Bernhard $u Department of Biomedicine, University of Basel, 4056 Basel, Switzerland. Electronic address: bernhard.bettler@unibas.ch.
773    0_
$w MED00000704 $t Biochemical pharmacology $x 1873-2968 $g Roč. 91, č. 3 (2014), s. 369-79
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25065880 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150709 $b ABA008
991    __
$a 20150728104017 $b ABA008
999    __
$a ok $b bmc $g 1083542 $s 906197
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 91 $c 3 $d 369-79 $i 1873-2968 $m Biochemical pharmacology $n Biochem Pharmacol $x MED00000704
LZP    __
$a Pubmed-20150709

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace